Introduction {#sec1-0300060518822404}
============

Sepsis and septic shock are the most common causes of death in hospitals. Sepsis is a frequently encountered systemic inflammatory response syndrome caused by infection; annually, 18 million patients receive treatment for sepsis.^[@bibr1-0300060518822404]^ A state of sepsis is extremely dangerous, and can develop rapidly, with a high fatality rate. Notably, sepsis (secondary to infection) and septic shock (sepsis accompanied by hypotension that is difficult to reverse with fluid resuscitation) are major causes of death for non-heart disease patients in the intensive care unit (ICU).^[@bibr2-0300060518822404]^ Currently, the diagnosis of such diseases is primarily based on biochemical indexes or pathogen detection through bacterial culture. Relevant biochemical tests lack high specificity, which leads to increased uncertainty in the diagnostic process and is challenging for clinicians. Importantly, the inability to accurately diagnose according to exact biochemical indicators often leads to delay or failure to carry out the appropriate clinical treatment, and clinicians cannot assess changes in blood conditions with sufficient time to modify treatment.^[@bibr3-0300060518822404][@bibr4-0300060518822404]--[@bibr5-0300060518822404]^ Bacterial culture has high specificity, but requires an extended incubation period; this leads to treatment delay, as well as antibiotic misuse and abuse. Because patients with sepsis and septic shock often exhibit cardiovascular and cerebrovascular diseases or endocrine diseases, the diagnostic process is highly complex and variable. The physical conditions of patients with sepsis or septic shock are severe, and these patients are often transferred to the ICU from emergency departments. Rapid and accurate disease diagnosis, as well as timely medical intervention, can help clinicians confirm the disease in an appropriate timeframe and make necessary treatment decisions. For example, according to the specificity of the biochemical indicators to determine the severity of infection, timely control of infection can be achieved through effective antibiotics or surgery to reverse the progress of the disease; clinicians can also monitor changes in disease. Procalcitonin (PCT), a prohormone of calcitonin, is encoded by the calcitonin-I (*CALC-1*) gene on chromosome 11, and comprises 114--116 amino acids. C-reactive protein (CRP) is an acute-phase reactive protein that can interact with capsule C polysaccharides of *Streptococcus pneumoniae*. Among the clinically useful biochemical detection indexes, PCT has shown superiority as an important reference marker for infection, as well as antibiotic management guidance.^[@bibr6-0300060518822404],[@bibr7-0300060518822404]^ Furthermore, some studies have shown that changes in PCT and CRP concentrations are related to the prognosis of patients with sepsis.^[@bibr8-0300060518822404]^ Use of these parameters may improve accuracy of judgment regarding the prognosis of infection. Thus, this study was performed involving adult patients who were hospitalized in the ICU due to sepsis or septic shock, to investigate the clinical significance of changes in serum PCT and CRP in these patients.

Materials and methods {#sec2-0300060518822404}
=====================

Criteria for inclusion in the study {#sec3-0300060518822404}
-----------------------------------

The study protocol was approved by the Ethics Committee of the Affiliated Hospital of Hebei University. Adult patients selected for this study were hospitalized in the ICU of the Affiliated Hospital of Hebei University during the period from March 2016 to July 2018. Inclusion criteria: 1) patients who met clinical diagnostic criteria for sepsis or septic shock; 2) patients who were between 55 and 80 years of age; 3) patients who provided written informed consent to participate in the study. Exclusion criteria: 1) patients who exhibited other cardiovascular and cerebrovascular diseases; 2) patients who exhibited an unrecoverable state of death or dying.

Kinetic study of PCT and CRP {#sec4-0300060518822404}
----------------------------

During early morning fasting, 5 mL of blood were collected from the elbow vein and added to an EDTA tube for 2 hours. The serum CRP level was detected by three processes: ELISA, CX20 automatic biochemical analyzer (Beckman Coulter, Brea, CA, USA), and immune turbidimetry. PCT was determined by electrochemiluminescence immunoassay (Cobas E601, Roche, Basel, Switzerland); calibration solution, reagent, and quality control products were also provided by Roche. PCT analysis was performed in accordance with the verification requirements of the Clinical and Laboratory Standards Institute (Guidelines EP15-A2). PCT kinetic changes were expressed as ΔPCT, and CRP kinetic changes were expressed as ΔCRP. PCTi referred to the PCT value of the ith day, and CRPi referred to the CRP value of the ith day, where i =1, 2, 3, 5 (1 represents the day of hospitalization). ΔPCTi/1 = \| (PCTi-PCT1) \|/PCT1, ΔCRPi/1 = \|(CRPi-CRP1)\|/CRP1, where i = 2, 3, 5;\|indicates absolute value in the preceding equation.

Statistical analysis {#sec5-0300060518822404}
--------------------

SPSS 21.0 statistical software was used for data analysis. The measurement data did not conform to a normal distribution; therefore, medians were used for statistical description (interquartile range). The A nonparametric rank-sum test (Mann-Whitney U test) was used for inter-group comparison. A two-sided P-value of \<0.05 was considered to indicate statistical significance.

Results {#sec6-0300060518822404}
=======

Patient Groups {#sec7-0300060518822404}
--------------

Fifty-nine patients met the criteria for inclusion in this study. In accordance with the disease severity and patient survival, the 59 patients were divided into septic shock (i.e., an acute circulatory disorder resulting from sepsis and hypoperfusion caused by systemic shock) and sepsis groups, as well as non-survivor and survivor groups ([Table 1](#table1-0300060518822404){ref-type="table"}). There were 37 patients in the survivor group (63%) and 22 patients in the non-survivor group (37%); there were 37 patients in the sepsis group (63%) and 22 patients in the septic shock group (37%).

###### 

Grouping of elderly patients in ICU.

![](10.1177_0300060518822404-table1)

  Group               Survivor      Non-survivor   Sepsis        Septic shock
  ------------------- ------------- -------------- ------------- --------------
  No. (n)             37            22             37            22
  Age                 67.2 ± 13.2   70.1 ± 12.6    67.1 ± 14.2   70.0 ± 10.9
  Sex (male:female)   23:14         14:8           22:15         15:7

Note: Sex is number of patients shown as a ratio.

Comparison of serum CRP changes {#sec8-0300060518822404}
-------------------------------

CRP levels in the non-survivor group on the 2nd, 3rd, and 5th days were higher than those in the survivor group (P = 0.0009, P = 0.0007, and P = 0.0001; [Table 2](#table2-0300060518822404){ref-type="table"}). In CRP kinetics comparison, the differences in CRP levels between the 2nd and 1st day, compared with CRP level on the 1st day (ΔCRP2/1); the differences in CRP levels between the 3rd and 1st day, compared with CRP level on the 1st day (ΔCRP3/1); and the differences in CRP levels between the 5th day and 1st day, compared with CRP level on the 1st day (ΔCRP5/1) were statistically significant (P = 0.012, P = 0.004, and P = 0.0001; [Table 3](#table3-0300060518822404){ref-type="table"}). On the 2nd, 3rd, and 5th days, serum CRP levels of patients in the septic shock group were higher than those of patients in the sepsis group (P = 0.025, P = 0.043, and P = 0.032; [Table 2](#table2-0300060518822404){ref-type="table"}). In kinetics comparison, only ΔCRP3/1 showed a significant difference (P = 0.025; [Table 3](#table3-0300060518822404){ref-type="table"}).

###### 

Comparison of serum C-reactive protein level (mg/L).

![](10.1177_0300060518822404-table2)

  Group          CRP1             CRP2             CRP3             CRP5
  -------------- ---------------- ---------------- ---------------- ---------------
  Survivor       115.0 (129.77)   91.9 (86.95)     71.0 (65.75)     31.2 (62.98)
  Non-survivor   163.3 (226.9)    169.3 (86.9)     136.4 (77.0)     95.7 (131.05)
  P              0.312            0.0009           0.0007           0.0001
  Sepsis         100.6 (132.18)   88.2 (59.15)     68.7 (80.6)      50.2 (112.1)
  Septic shock   138.0 (73.99)    197.05 (92.33)   196.5 (149.15)   234.1 (166.6)
  P              0.0818           0.0250           0.0431           0.0317

Note: Median outside parentheses and quartile spacing inside parentheses. CRP: C-reactive protein.

###### 

Comparison of serum C-reactive protein kinetics (ΔCRP in mg/L).

![](10.1177_0300060518822404-table3)

  Group          ΔCRP2/1       ΔCRP3/1       ΔCRP5/1
  -------------- ------------- ------------- -------------
  Survivor       0.35 (0.19)   0.54 (0.26)   0.79 (0.31)
  Non-survivor   0.26 (0.21)   0.40 (0.22)   0.50 (0.29)
  P              0.0123        0.0036        0.0001
  Sepsis         0.34 (0.14)   0.53 (0.26)   0.66 (0.37)
  Septic shock   0.29 (0.24)   0.41 (0.31)   0.62 (0.43)
  P              0.4373        0.0254        0.3884

Note: Median outside parentheses and quartile spacing inside parentheses. CRP: C-reactive protein.

Comparison of serum PCT level change {#sec9-0300060518822404}
------------------------------------

Regarding changes in serum PCT level, levels in the non-survivor group on the 2nd, 3rd, and 5th days were higher than those in the survivor group (P = 0.0001 for all comparisons; [Table 4](#table4-0300060518822404){ref-type="table"}), whereas the sepsis and septic shock groups showed no statistical differences ([Table 4](#table4-0300060518822404){ref-type="table"}). In serum PCT kinetics comparison of survivor and non-survivor groups, the differences in PCT levels between the 2nd and 1st day, compared with PCT level on the 1st day (ΔPCT2/1), and the differences in PCT levels between the 3rd and 1st day, compared with PCT level on the 1st day (ΔPCT3/1) were statistically significant (P = 0.012, P = 0.004; [Table 5](#table5-0300060518822404){ref-type="table"}). In contrast, the differences in PCT levels between the 5th day and 1st day, compared with PCT level on the 1st day (ΔPCT5/1), did not show a significant difference. In serum PCT kinetics comparison of sepsis and septic shock groups, there were no statistical differences ([Table 5](#table5-0300060518822404){ref-type="table"}).

###### 

Comparison of serum procalcitonin level (ng/L).

![](10.1177_0300060518822404-table4)

  Group          PCT1            PCT2            PCT3            PCT5
  -------------- --------------- --------------- --------------- ---------------
  Survivor       8.36 (22.98)    2.64 (11.08)    1.22 (8.55)     0.66 (6.34)
  Non-survivor   53.60 (40.73)   34.66 (24.77)   19.36 (14.32)   15.46 (16.05)
  P              0.0001          0.0001          0.0001          0.0001
  Sepsis         23.39 (39.82)   11.37 (31.93)   8.77 (20.39)    2.88 (12.70)
  Septic shock   21.20 (61.02)   9.04 (36.02)    6.45 (16.77)    3.88 (19.84)
  P              0.9875          0.8878          0.8693          0.4612

Note: Median outside parentheses and quartile spacing inside parentheses. PCT: procalcitonin.

###### 

Comparison of serum procalcitonin kinetics (ΔPCT in ng/L).

![](10.1177_0300060518822404-table5)

  Group          ΔPCT2/1       ΔPCT3/1       ΔPCT5/1
  -------------- ------------- ------------- -------------
  Survivor       0.66 (0.49)   0.80 (0.28)   0.88 (0.27)
  Non-survivor   0.28 (0.25)   0.56 (0.28)   0.71 (0.18)
  P              0.0003        0.0005        0.0322
  Sepsis         0.42 (0.50)   0.70 (0.33)   0.80 (0.26)
  Septic shock   0.44 (0.46)   0.71 (0.31)   0.74 (0.31)
  P              0.6325        0.8019        0.1956

Note: Median outside parentheses and quartile spacing inside parentheses. PCT: procalcitonin.

Discussion {#sec10-0300060518822404}
==========

Currently, PCT level kinetics and CRP level kinetics have become the focus of research efforts for identification and assessment of disease prognosis.^[@bibr9-0300060518822404],[@bibr10-0300060518822404]^ Under normal physiological conditions, the levels of serum PCT and CRP are very low, and are maintained at a relative equilibrium in the body. When sepsis is caused by an inflammatory stimulus due to pathogen infection, the levels of serum PCT and CRP increase rapidly due to the host response to infection. PCT is an effective biochemical indicator of the severity of infection in patients with sepsis. PCT of 2 ng/mL indicates sepsis or septic shock.^[@bibr11-0300060518822404][@bibr12-0300060518822404]--[@bibr13-0300060518822404]^ CRP values can increase over 100-fold greater than baseline values, which indicate an active state of infection.

In this study, PCT and CRP tests were conducted for 59 elderly patients in the ICU who were diagnosed with sepsis/septic shock to further assess the significance of PCT, CRP, and dynamic changes in their levels with regard to the diagnosis and prognosis of sepsis and septic shock. Sepsis and septic shock, as well as multiple organ dysfunction syndrome (caused by the onset of sepsis), are the primary causes of death among ICU patients.^[@bibr14-0300060518822404]^ Thus far, the annual fatality rate of sepsis (secondary to infection) and septic shock (sepsis accompanied by hypotension that is difficult to reverse with fluid resuscitation) has continued to increase (up to 80%).^[@bibr15-0300060518822404]^ Some studies have indicated that PCT and CRP may serve as references with regard to the diagnosis of sepsis, but their abilities to support determination of sepsis prognosis need further investigation.^[@bibr16-0300060518822404],[@bibr17-0300060518822404]^ By comparing changes in the kinetics of serum PCT and CRP levels of patients with sepsis and those with septic shock, we found that increasing levels of PCT can distinguish sepsis or septic shock. Thus, PCT can serve as an effective chemical biomarker to evaluate the degree of infection among patients with sepsis.

Sepsis is not a single disease, and clinically manifests as a highly heterogeneous syndrome. Importantly, it is the result of interactions between host and pathogen.^[@bibr18-0300060518822404]^ Among elderly patients, sepsis and septic shock are often accompanied by compromised cardiac function, pathologic pulmonary changes, and urinary system abnormalities.^[@bibr19-0300060518822404],[@bibr20-0300060518822404]^ In the present study, we investigated the use of changes in PCT and CRP as biomarkers of sepsis severity, specifically among elderly patients. The complicated pathological and physiological changes of elderly patients with sepsis involve changes in multiple biomarkers, as well as in multiple tissue and organ systems. Regarding changes in serum PCT levels, there were significant differences between survivor and non-survivor groups, while the sepsis and septic shock groups showed no statistical differences. The results of serum PCT kinetics (ΔPCT) analyses were similar. This study showed that, compared with the levels in the survivor group, PCT and CRP levels of the non-survivor group on the 5th day exhibited an increasing trend. Notably, increased CRP level was indicative of poor prognosis. We found that, when assessing the severity of sepsis in elderly patients, PCT was more clinically useful than CRP. Furthermore, studies of PCT kinetics were more useful than studies of the unadjusted PCT level. Compared with CRP, PCT is a favorable marker for assessing changes in clinical symptoms and patient prognosis. PCT can enhance the judgment of disease severity among patients with sepsis and those with septic shock, thereby improving the ability of clinicians to accurately assess disease prognosis.^[@bibr21-0300060518822404]^ Thus, we propose that PCT should be assessed daily for patients with sepsis who are hospitalized in the ICU.

Conclusion {#sec11-0300060518822404}
==========

In conclusion, PCT and CRP may aid in diagnosis and judgment of the prognosis of sepsis. Thus, these markers may change the nature of sepsis from a clinically defined physiological syndrome to a disease entity that can be defined by specific biochemical indexes; this change may further contribute to the development of better biochemical diagnosis capabilities and effective assistance in infection treatment. Therefore, research and development of specific biochemical markers and molecular diagnoses for sepsis and septic shock can improve assessment of patients' disease and facilitate detection of pathogens; it can also promote more accurate drug use and improved clinical management of sepsis. Importantly, PCT and CRP cannot meet all needs and expectations for diagnosis and management of treatment for patients with sepsis and those with septic shock. Finally, a combination of PCT and CRP biomarkers may serve as an enhanced index to assess the prognosis of patients with sepsis and septic shock, and should be investigated in future studies.
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